Abbott’s Simcor Significantly Lowers Non-HDL Cholesterol In SEACOAST Phase III Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Simcor, with a Feb. 20 user fee date, could face competition from two Merck investigational extended-release niacin combinations, including Cordaptive (laropiprant), with an anticipated FDA action date in Q2 2008.